DK2211180T3 - Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer - Google Patents

Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer

Info

Publication number
DK2211180T3
DK2211180T3 DK10158956.2T DK10158956T DK2211180T3 DK 2211180 T3 DK2211180 T3 DK 2211180T3 DK 10158956 T DK10158956 T DK 10158956T DK 2211180 T3 DK2211180 T3 DK 2211180T3
Authority
DK
Denmark
Prior art keywords
marker
cancers
colorectal cancer
satb2
protein
Prior art date
Application number
DK10158956.2T
Other languages
Danish (da)
English (en)
Inventor
Mathias Uhlen
Fredrik Ponten
Original Assignee
Atlas Antibodies Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atlas Antibodies Ab filed Critical Atlas Antibodies Ab
Application granted granted Critical
Publication of DK2211180T3 publication Critical patent/DK2211180T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK10158956.2T 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer DK2211180T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06114954A EP1862803A1 (en) 2006-06-02 2006-06-02 Use of protein SATB2 as a marker for colorectal cancer
US81661306P 2006-06-27 2006-06-27
EP07725799A EP2024747B1 (en) 2006-06-02 2007-06-04 Use of protein satb2 as a prognostic marker for colorectal cancer

Publications (1)

Publication Number Publication Date
DK2211180T3 true DK2211180T3 (da) 2011-09-26

Family

ID=36968849

Family Applications (2)

Application Number Title Priority Date Filing Date
DK10158956.2T DK2211180T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
DK07725799.6T DK2024747T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK07725799.6T DK2024747T3 (da) 2006-06-02 2007-06-04 Anvendelse af protein SATB2 som prognotisk markør for colerectal cancer

Country Status (11)

Country Link
US (3) US8067190B2 (enExample)
EP (3) EP1862803A1 (enExample)
JP (2) JP4990970B2 (enExample)
CN (2) CN103293307B (enExample)
AT (2) ATE514090T1 (enExample)
AU (1) AU2007256391B2 (enExample)
CA (1) CA2653952A1 (enExample)
DK (2) DK2211180T3 (enExample)
ES (1) ES2367412T3 (enExample)
PL (1) PL2211180T3 (enExample)
WO (1) WO2007140966A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100662821B1 (ko) * 2006-04-05 2006-12-28 유니트마 주식회사 레시피언트 블록 성형용 몰드 및 이를 이용한 레시피언트블록의 제조방법
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer
EP2107375A1 (en) * 2008-03-31 2009-10-07 Atlas Antibodies AB Uses of WARS protein in cancer prognostics
EP2172477A1 (en) * 2008-10-06 2010-04-07 Atlas Antibodies AB Epitopes derived from SATB2 and uses thereof
EP2396657B1 (en) * 2009-02-16 2013-11-13 Atlas Antibodies AB Rbm3 as a marker for malignant melanoma prognosis
US11506663B2 (en) 2014-05-13 2022-11-22 Vastcon Methionine aminopeptidase overexpression in the peripheral blood and peripheral blood mononuclear cells is a marker for colorectal cancer screening, diagnosis and prognosis
US11326210B2 (en) * 2015-01-30 2022-05-10 Glax Llc Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
US20160258438A1 (en) * 2015-03-05 2016-09-08 Regal Beloit America, Inc. Assembly, blower and associated method
US20180282815A1 (en) * 2015-04-29 2018-10-04 Geneoscopy, Llc Colorectal cancer screening method and device
AU2017348369B2 (en) 2016-10-27 2023-09-28 Geneoscopy, Inc. Detection method
CN106841131A (zh) * 2016-12-29 2017-06-13 上海交通大学 一种基于角蛋白自荧光作为预测检测肿瘤的生物标志物的检测方法及其应用
AU2019276577B2 (en) 2018-06-01 2025-09-11 Geneoscopy, Inc. Detection method
EP3833779A4 (en) * 2018-08-08 2022-05-11 Indian Institute Of Science Education And Research COMBINED EXPRESSION PATTERN OF SATB FAMILY CHROMATIN ORGANIZERS AS AN IMPROVED BIOMARKER TOOL FOR CANCER PREDICTION
US12435335B2 (en) 2022-06-06 2025-10-07 Cornell University Promoting nutrient absorption through the colon

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828840D0 (en) 1998-12-30 1999-02-17 Univ Nottingham Trent Prostate cancer associated genes and their products
DE19932688B4 (de) 1999-07-13 2009-10-08 Scil Proteins Gmbh Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
US20030129207A1 (en) * 2001-08-21 2003-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of colon cancer
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
EP2177614B1 (en) * 2005-05-02 2014-12-31 Toray Industries, Inc. Composition and method for diagnosing esophageal cancer and metastasis of esophageal cancer
GB2435882A (en) 2006-03-09 2007-09-12 Bioinvent Int Ab Detection and treatment of mantle cell lymphoma
EP1862803A1 (en) 2006-06-02 2007-12-05 Atlas Antibodies AB Use of protein SATB2 as a marker for colorectal cancer

Also Published As

Publication number Publication date
CA2653952A1 (en) 2007-12-13
JP4990970B2 (ja) 2012-08-01
PL2211180T3 (pl) 2011-11-30
ATE513216T1 (de) 2011-07-15
US8465934B2 (en) 2013-06-18
EP2211180A1 (en) 2010-07-28
JP5301630B2 (ja) 2013-09-25
EP1862803A1 (en) 2007-12-05
EP2024747B1 (en) 2011-06-15
JP2012073260A (ja) 2012-04-12
US8241859B2 (en) 2012-08-14
EP2211180B1 (en) 2011-06-22
AU2007256391A1 (en) 2007-12-13
CN103293307A (zh) 2013-09-11
US20090220975A1 (en) 2009-09-03
CN101460850A (zh) 2009-06-17
EP2024747A1 (en) 2009-02-18
WO2007140966A1 (en) 2007-12-13
US20120028836A1 (en) 2012-02-02
CN103293307B (zh) 2016-03-23
US8067190B2 (en) 2011-11-29
AU2007256391B2 (en) 2011-05-19
ES2367412T3 (es) 2011-11-03
JP2009539082A (ja) 2009-11-12
ATE514090T1 (de) 2011-07-15
US20120270956A1 (en) 2012-10-25
DK2024747T3 (da) 2011-09-19

Similar Documents

Publication Publication Date Title
DK2211180T3 (da) Anvendelse af protein SATB2 som markør til at skelne colorectal cancer fra andre former for cancer
WO2006089125A3 (en) Methods of detecting ovarian cancer
WO2010009368A3 (en) Compositions for the detection and treatment of colorectal cancer
WO2009037572A3 (en) Biomarker combinations for colorectal cancer
DK2438446T3 (da) Fremgangsmåder, reagenser og kits til flowcytometrisk immunfænotypebestemmelse
MX2007010349A (es) Composiciones y metodos para clasificar muestras biologicas.
CU20120095A7 (es) Antagonistas de pcsk9
EP2611941A4 (en) GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
WO2010009337A3 (en) Signatures and pcdeterminants associated with prostate cancer and methods of use thereof
LT3656793T (lt) Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui
WO2008097908A3 (en) Methods of diagnosing and prognosing lung cancer
EA201190210A1 (ru) Ингибиторы связывания киназы с белком
WO2011047087A3 (en) Protein detection via nanoreporters
ATE527385T1 (de) Mit tumoren assoziierte genetische variationen
ATE518860T1 (de) Pyrroloä2,3-büpyridinderivate als proteinkinaseinhibitoren
EP1824520A4 (en) METHOD FOR DETECTING PROSTATE CARCINOMA
WO2012021887A3 (en) Biomarkers for the early detection of breast cancer
DK2135091T3 (da) MS-fremgangsmåder til evaluering af glykaner
NO20073356L (no) Dampkompresjons-kjolesystem med lukket krets samt fremgangsmate for drift av systemet.
IL220619A (en) Pancreatic cancer markers, detection methods, kits and their biological chips
DK3106874T3 (da) Fremgangsmåde til detektering af cancer
EP2281903A4 (en) CANCER MARKER, METHOD FOR EVALUATING CANCER USING THE CANCER MARKER AND ASSESSING THE VALUE
GB0724881D0 (en) Methods for the detection of colorectal cancer
EP2576832A4 (en) COMPOSITIONS AND METHODS FOR DETECTING NEOPLASIA
EP1934603A4 (en) BIOMARKER FOR PROSTATE CANCER